Pharma Marketers Breaking Through Regulations
Susan Perlbachs, chief creative officer of Eversana Intouch, discusses how marketers are navigating a new world order of scrutiny.
Recently, the FDA released a wave of untitled and warning letters, extending to influencers, telehealth, digital, and even search, with violations ranging from omitted safety risks to misleading equivalency claims.
However, creativity doesn't have to retreat. The following campaigns show how marketers can break through while avoiding regulatory fault lines.
- Ask for Clear: Novartis and Havas Lynx's unbranded campaign in the U.K. nodded to Cosentyx's endpoint of "skin clearance," a savvy choice under today's regulatory pressures.
These four campaigns show how marketers can break through while avoiding the new regulatory fault lines FDA has drawn.
Author's summary: Pharma marketers can navigate regulations with creative campaigns.